Government Affairs
Refine Search
Pharmaceutical
The outgoing chief executive of troubled Canadian drugmaker Valeant Pharmaceuticals has admitted to a US Senate committee that he made mistakes in leading the company’s "aggressive" strategy on buying old drugs and increasing their prices. 28 April 2016
Biosimilars
European Parliament calls for action under the previously annoiunced Single Market Strategy for Europe on generics and biosimilars. 25 April 2016
Pharmaceutical
A new fast-track system to get the most innovative and transformative drugs to patients more quickly could be introduced in England and Wales, a conference has heard. 22 April 2016
Pharmaceutical
Russia may start the use of the recently-announced practice of compulsory licensing of drugs already in the coming weeks. 22 April 2016
Pharmaceutical
20 civil society associations are urging European Union member states to support the Dutch EU Presidency’s vision on access to affordable medicines. The call for backing comes as Health Ministers meet in Amsterdam this week, according to posting on the website of the European Public Health Alliance. 20 April 2016
Generics
Concerned at being sidelined from the USA-led Trans-Pacific Partnership (TPP) trade deal, India is preparing to reach a deal this year amidst preparations to deal with the adverse impact. 18 April 2016
Pharmaceutical
US Republic Presidential contender Donald Trump recently released a healthcare reform plan, which the presigious US think-tank Pacific Research Institute (PRI) has assessed. 13 April 2016
Pharmaceutical
Is now the right time to invest in China? If yes, what kind of startups are the best bet? What is considered an innovative business model in current China? These are the questions lively discussed at the 2016 China Healthcare Investment Conference (CHIC), which was held in Shanghai in late March, reports The Pharma Letter’s local correspondent Wang Fangqing. 12 April 2016
Pharmaceutical
According to media reports this morning, the US Senate Committee on Aging may soon start contempt proceedings against Canadian drugmaker Valeant Pharmaceuticals International's (TSX: VRX) Michael Pearson. 11 April 2016
Pharmaceutical
Less red tape for clinical trials will benefit patients and researchers, says Australian trade group
In Australia, Health Ministers in Perth have announced work towards a national framework for clinical trials. 11 April 2016
Pharmaceutical
Stories about the pharmaceutical industry which have made headline news in recent months have not done the sector’s reputation any favors. 11 April 2016
Biotechnology
Representatives of governments, healthcare providers, academia and industry from 15 countries gathered in the UK to explore collaborations aimed at developing their local genomics capability. 8 April 2016
Biotechnology
The trade group representing Australia’s biotech industry has moved to clear up confusion over the proposed Australian Innovation and Manufacturing’ (AIM) Incentive. 7 April 2016
Pharmaceutical
The planned $160 billion mega-merger of US pharma giant Pfizer and Ireland-domiciled Allergan will be called off, with an official announcement expected to be released today, according to media reports. 6 April 2016
Biosimilars
A critical response has been given to draft new guidance issued by the US Food and Drug Administration on the labeling of biosimilars by the Alliance for Patient Access (AfPA). 5 April 2016
Generics
Russia has come one step closer to the establishment of production of foreign drugs at the facilities of domestic enterprises, as the Russian Federal Antimonopoly Service (FAS) has officially announced that it has completed the design of a scheme of compulsory licensing of imported vital drugs. 5 April 2016
Generics
The Indonesian government last week released the 11th economic stimulus package with the aim of boosting the domestic production of medicines' raw materials, particularly for five product categories: biotechnology, vaccines, herbal extracts, active pharmaceutical ingredients and medical devices. 4 April 2016
Pharmaceutical
The Australian Minister for Health, Sussan Ley, has announced that patients will see the cost of their prescriptions for common medicines drop by as much as 60% as part of government reforms. 4 April 2016
Pharmaceutical
US Congress has written to the National Institutes of Health (NIH) questioning the price Americans are charged for the prostate cancer drug Xtandi (enzalutamide) by Japanese company Astellas Pharma. 30 March 2016
Biotechnology
A joint action plan has been set into motion in India to help the biotech sector reach $100 billion by 2025. 29 March 2016
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze